Literature DB >> 15857183

Phenotypic heterogeneity in patients with Gaucher disease and the N370S/V394L genotype.

Deborah Elstein1, C Ronald Scott, Marsha Zeigler, Aya Abrahamov, Ari Zimran.   

Abstract

Correlation between genotype and phenotype in Gaucher disease is limited. It is known that the most common mutation N370S is protective of neurological involvement, but for the V394L mutation, described as the fifth most common among Ashkenazi Jews, little data are available. This study reports all known patients from a large referral clinic and from the international registry with Gaucher disease who are documented to have the N370S/V394L genotype. Of 476 patients in the Gaucher Clinic, 7 patients (2.0%) had the N370S/V394L genotype; of 2,836 patients in the registry, there were 14 patients (0.8%) with this genotype. There was an overlap of 3 patients, making a total of 18 patients, reflecting the rarity of this genotype among the studied cohorts. Most of these patients had mild disease; only 8 patients required specific enzyme therapy, none was splenectomized. Only 3 patients had skeletal involvement, but other baseline parameters were very diverse. Although genotype-phenotype correlation in this case may be difficult, because the V394L mutation when seen in a compound heterozygote with a null allele results in neuronopathic disease, one cannot conclude that this mutation is protective of neuronopathic disease and hence this is important for counseling of at-risk populations.

Entities:  

Mesh:

Year:  2005        PMID: 15857183     DOI: 10.1089/gte.2005.9.26

Source DB:  PubMed          Journal:  Genet Test        ISSN: 1090-6576


  2 in total

1.  Patients with type 1 Gaucher disease in South Florida, USA: demographics, genotypes, disease severity and treatment outcomes.

Authors:  Marissa Orenstein; Deborah Barbouth; Olaf A Bodamer; Neal J Weinreb
Journal:  Orphanet J Rare Dis       Date:  2014-03-31       Impact factor: 4.123

2.  Substrate compositional variation with tissue/region and Gba1 mutations in mouse models--implications for Gaucher disease.

Authors:  Ying Sun; Wujuan Zhang; You-Hai Xu; Brian Quinn; Nupur Dasgupta; Benjamin Liou; Kenneth D R Setchell; Gregory A Grabowski
Journal:  PLoS One       Date:  2013-03-08       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.